Back to BMYView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Unresectable or Metastatic Melanoma
View Full LandscapeDrug Information
Target Indication
Unresectable or Metastatic Melanoma
Clinical Trial
NCT04674683Last updated: 10/21/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Topical DapsonePhase 3
Cetuximab-induced Papulopustular (Acneiform) Rash Who Have
Tegafur-gimeracil-oteracil potassiumPhase 3
Gastric Cancer
oral antibioticsPhase 3
Cetuximab-induced Papulopustular (Acneiform) Rash Who Have
Anti-Tumor Necrosing Factor (TNF) TherapyPhase 3
Rheumatoid Arthritis
Irbesartan/HCTZPhase 3
Hypertension
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts